Form 4 for BMEA Biomea Fusion, Inc.
Accepted 2023-05-17 00:00:00 ET · period of report 2023-05-12 · accession 0001859061-23-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-17 | 2023-05-12 | BMEA | A2A Pharmaceuticals, Inc. | 10% | S - Sale | $33.84 | -25.0K | 3.62M | -0.7% | -$846.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-12 | S | D | 25,000 | $33.84 | 3,625,000 | D | — | — | (F1) A total of 25,000 shares were sold at an average price of 33.84 in multiple transactions in a range of 33.50 to 34.50. Details of the specific transactions are available upon request. |